- Home
- PLRX vs CIRC Comparison
PLRX vs CIRC Comparison
Compare PLRX & CIRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.05
Company Overview
Basic Information| Metric | PLRX | CIRC |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.7M | 67.3M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PLRX | CIRC |
|---|---|---|
| Price | $1.05 | $0.48 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $2.67 | N/A |
| AVG Volume (30 Days) | 360.8K | ★ 487.8K |
| Earning Date | 11-05-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.97 | ★ 70.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $78,659.00 |
| Revenue This Year | N/A | $10.37 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.02 | $0.31 |
| 52 Week High | $1.95 | $0.98 |
Technical Indicators
Market Signals| Indicator | PLRX | CIRC |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 49.05 |
| Support Level | $1.02 | $0.48 |
| Resistance Level | $1.37 | $0.80 |
| Average True Range (ATR) | 0.04 | 0.06 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 18.18 | 78.84 |
Price Performance
Historical Comparison PLRX
CIRC
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.